- Home
- Products
- Customized ADCs
- CD72
- Anti-CD72-SPP-DM1 ADC
Anti-CD72-SPP-DM1 ADC (CAT#: ADC-W-609)
This ADC product is comprised of an anti-CD72 monoclonal antibody (10D6.8.1) conjugated via a SPP linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DM1 binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- CD72
- Alternative Names
- CD72; CD72 molecule; LYB2; CD72b; B-cell differentiation antigen CD72; lyb-2; CD72 antigen;
- Target Entrez Gene ID
- 971
- Target UniProt ID
- P21854
- Overview
- CD72 (Cluster of Differentiation 72), also known in murine biology as Lyb-2, is a protein active in the immune system of animals. It consists of two identical halves, each of about 39-43 kD, and is a C-type lectin. Its primarily locus of expression is B-cells, where it appears to mediate aspects of B-cell-T-cell interaction. It is a ligand for CD5.
- Overview
- Anti-CD72 IgG1 Antibody, 10D6.8.1
- Generic name
- 10D6.8.1
- Species Reactivity
- Human
- Name
- SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Description
- Disulfide Linkers, are extensively exploited as a chemically labile linkage. Since the release of disulfide-linked drugs requires a cytoplasmic thiol cofactor, such as glutathione (GSH). Disulfides maintain stable at physiological pH and only when ADCs are internalized inside cells, the cytosol provides reducing environment including intracellular enzyme protein disulfide isomerase, or similar enzymes, drugs can be released.
- Name
- DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine)
- Description
- Derived from Maytansinoid,a group of cytotoxins structurally similar to rifamycin, geldanamycin, and ansatrienin. The eponymous natural cytotoxic agent maytansine is a 19-member lactam (ansa
macrolide) structure originally isolated from the Ethiopian shrub Maytenus ovatus. Maytansinoids can bind to tubulin at or near the vinblastine-binding site, which interfere the formation of microtubules and depolymerize already formed microtubules, inducing mitotic arrest in the intoxicated cells.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MUC1 (Pemtumomab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-2430)
- Anti-CEACAM5 (Altumomab)-MC-MMAF ADC (CAT#: ADC-W-970)
- Anti-CD19 (Taplitumomab paptox)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-773)
- Anti-IGF2 (Dusigitumab)-SPDB-DM4 ADC (CAT#: ADC-W-1269)
- Anti-FUT4 (Technetium (99mTc) fanolesomab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1176)
- Anti-MET (Onartuzumab)-SMCC-DM1 ADC (CAT#: ADC-W-1538)
- Anti-CD80 (Galiximab)-SPDB-DM4 ADC (CAT#: ADC-W-957)
- Anti-ITGB3 (Tadocizumab)-SMCC-DM1 ADC (CAT#: ADC-W-2604)
- Anti-CA9 (Girentuximab)-SMCC-DM1 ADC (CAT#: ADC-W-740)
- Anti-CSF2 (Namilumab)-MC-MMAF ADC (CAT#: ADC-W-988)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-609. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-611 | Anti-CD72-Mc-VC-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
| ADC-W-610 | Anti-CD72-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-612 | Anti-CD72-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-317 | Anti-MUC1-SPP-DM1 ADC-4 | SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-605 | Anti-ERBB2-SPP-DM1 ADC | SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-222 | Anti-CD79b-SPP-DM1 ADC-7 | SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-233 | Anti-MUC1-SPP-[3H]DM1 ADC-2 | SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate) | [3H]DM1([3H]N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine) |
| ADC-W-597 | Anti-NCAM1-SPP-[3H]DM1 ADC | SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate) | [3H]DM1([3H]N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-541 | Anti-CD44-DM1 ADC | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) | |
| ADC-AA-026 | anti-MIgG(Fc)-N-DM1 ADC | Noncleavable linkers | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-AA-050 | Protein G-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-496 | Anti-EGFR-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-495 | Anti-EGFR-SMCC-DM1 ADC-4 | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.